Insider Trading Alert - CVS, TIS And SVVC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 4, 2015, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1.50 to $744,000,000,054.72.

Highlighted Stocks Traded by Insiders:

CVS Health (CVS) - FREE Research Report

Brown C David Ii, who is Director at CVS Health, sold 15,000 shares at $100.27 on May 4, 2015. Following this transaction, the Director owned 101,252 shares meaning that the stake was reduced by 12.9% with the 15,000-share transaction.

The shares most recently traded at $99.15, down $1.12, or 1.13% since the insider transaction. Historical insider transactions for CVS Health go as follows:

  • 4-Week # shares sold: 5,082
  • 12-Week # shares sold: 36,305
  • 24-Week # shares sold: 40,525

The average volume for CVS Health has been 4.6 million shares per day over the past 30 days. CVS Health has a market cap of $114.0 billion and is part of the health care sector and health services industry. Shares are up 4.31% year-to-date as of the close of trading on Monday.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The stock currently has a dividend yield of 1.39%. The company has a P/E ratio of 25.4. Currently, there are 16 analysts who rate CVS Health a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CVS - FREE

TheStreet Quant Ratings rates CVS Health as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full CVS Health Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Orchids Paper Products (TIS) - FREE Research Report

Berlin Steven R, who is Director at Orchids Paper Products, bought 1,500 shares at $22.66 on May 4, 2015. Following this transaction, the Director owned 14,150 shares meaning that the stake was boosted by 11.86% with the 1,500-share transaction.

The shares most recently traded at $22.67, up $0.01, or 0.06% since the insider transaction. Historical insider transactions for Orchids Paper Products go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 3,000
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 3,000
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 3,000

The average volume for Orchids Paper Products has been 69,900 shares per day over the past 30 days. Orchids Paper Products has a market cap of $192.2 million and is part of the consumer goods sector and consumer non-durables industry. Shares are down 24.6% year-to-date as of the close of trading on Monday.

Orchids Paper Products Company manufactures and sells tissue products for at-home and away from home markets in the United States. Its products include paper towels, bathroom tissues, and paper napkins. The stock currently has a dividend yield of 6.38%. The company has a P/E ratio of 19.8. Currently, there is 1 analyst who rates Orchids Paper Products a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TIS - FREE

TheStreet Quant Ratings rates Orchids Paper Products as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Orchids Paper Products Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Firsthand Technology Value Fund (SVVC) - FREE Research Report

Landis Kevin M, who is President at Firsthand Technology Value Fund, bought 16,000 shares at $15.04 on May 4, 2015. Following this transaction, the President owned 188,248 shares meaning that the stake was boosted by 9.29% with the 16,000-share transaction.

The shares most recently traded at $14.15, down $0.89, or 6.26% since the insider transaction. Historical insider transactions for Firsthand Technology Value Fund go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 147,044
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 147,044
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 172,514

The average volume for Firsthand Technology Value Fund has been 50,200 shares per day over the past 30 days. Firsthand Technology Value Fund has a market cap of $129.1 million and is part of the financial sector and financial services industry. Shares are down 24.13% year-to-date as of the close of trading on Friday.

Firsthand Technology Value Fund, Inc. is a business development company specializes in investments in start-up, late, development stage, and PIPEs. It seeks to invest in pre-IPO companies. The company has a P/E ratio of 3.7.

Exclusive Offer: Get the latest Stock Analysis on SVVC - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs